A study of blood parameters in rabbits with otitis caused by Malassezia pachydermatis and the effect of Farnesol on recovery rates when added to the treatment regimen

Cover Page

Cite item

Full Text

Abstract

Malassezia otitis is very common disease among animals. In previous years, successful, published work was carried out on modeling Malassezia otitis in rabbits using a Malassezia pachydermatis strain taken from dogs. We reproduced this experiment — we induced a clinical picture of the disease in order to try different treatment regimens on this model. The study involved 35 rabbits. The animals were divided into 7 groups of 5 rabbits each. Each group received one of the following drugs: Surolan; Otifri; Otoxolan; Surolan + Farnesol 200 μM/ml; Otifri + Farnesol 200 μM/ml; Otoxolan + Farnesol 200 μM/ml; control without treatment. All drugs were applied to the entire affected surface of the ear. The treatment was carried out once a day, the duration of treatment was 30 days. It was found that the use of drugs in combination with Farnesol in animals of the experimental group reduced the clinical signs of the disease; elimination of fungi in smears occurred more quickly; clinical parameters of rabbit blood improved.

About the authors

Ifarajimi R. Olabode

RUDN University

Author for correspondence.
Email: 1042205126@rudn.ru
ORCID iD: 0000-0003-2395-7350
SPIN-code: 7155-3985

PhD student, Department of Veterinary Medicine, Agrarian and Technological Institute

6 Miklukho-Maklaya st., Moscow, 117198, Russian Federation

Nadezhda P. Sachivkina

RUDN University

Email: sachivkina@yandex.ru
ORCID iD: 0000-0003-1100-929X
SPIN-code: 1172-3163

Candidate of Biological Sciences, Associate Professor, Department of Veterinary Medicine, Agrarian and Technological Institute

6 Miklukho-Maklaya st., Moscow, 117198, Russian Federation

Sergey Y. Smolentsev

Mari State University

Email: smolentsev82@mail.ru
ORCID iD: 0000-0002-6086-1369
SPIN-code: 8507-7106

Doctor of Biological Sciences, Associate Professor, Professor of the Department of Livestock Production Technology, Agrarian and Technological Institute

1 Lenina Square, Yoshkar-Ola, 424000, Russian Federation

References

  1. Cafarchia C, Immediato D, Paola GD, Magliani W, Ciociola T, Conti S, et al. In vitro and in vivo activity of a killer peptide against Malassezia pachydermatis causing otitis in dogs. Med Mycol. 2014;52(4):350—355. doi: 10.1093/mmy/myt016
  2. Olabode IR, Sachivkina NP, Kiseleva EV, Shurov AI. Effectiveness of Farnesol for treatment of dog otitis complicated by Malassezia pachydermatis. RUDN Journal of Agronomy and Animal Industries. 2023;18(2):250—263. doi: 10.22363/2312-797X 2023-18-2-250-263
  3. Peano A, Johnson E, Chiavassa E, Tizzani P, Guillot J, Pasquetti M. Antifungal resistance regarding Malassezia pachydermatis: where are we now? J Fungi. 2020;6(2):93. doi: 10.3390/jof6020093
  4. Lee TH, Hyun JE, Kang YH, Baek SJ, Hwang CY. In vitro antifungal activity of cold atmospheric microwave plasma and synergistic activity against Malassezia pachydermatis when combined with chlorhexidine gluconate. Vet Med Sci. 2022;8(2):524—529. doi: 10.1002/vms3.719
  5. Nakano Y, Wada M, Tani H, Sasai K, Baba E. Effects of beta-thujaplicin on anti-­Malassezia pachydermatis remedy for canine otitis externa. J Vet Med Sci. 2005;67(12):1243—1247. doi: 10.1292/jvms.67.1243
  6. Shin J, Bae S. In vitro effects of omeprazole in combination with antifungal compounds against Malassezia pachydermatis. Vet Med Sci. 2023;9(6):2594—2599. doi: 10.1002/vms3.1305
  7. Cafarchia C, Gallo S, Capelli G, Otranto D. Occurrence and population size of Malassezia spp. in the external ear canal of dogs and cats both healthy and with otitis. Mycopathologia. 2005;160:143—149. doi: 10.1007/s11046-005-0151 x
  8. Torres M, Pinzón EN, Rey FM, Martinez H, Parra Giraldo CM, Celis Ramírez AM. Galleria mellonella as a novelty in vivo model of host-pathogen interaction for Malassezia furfur CBS 1878 and Malassezia pachydermatis CBS 1879. Front Cell Infect Microbiol. 2020;10:199. doi: 10.3389/fcimb.2020.00199
  9. Pinchbeck LR, Hillier A, Kowalski JJ, Kwochka KW. Comparison of pulse administration versus once daily administration of itraconazole for the treatment of Malassezia pachydermatis dermatitis and otitis in dogs. J Am Vet Med Assoc. 2002;220(12):1807—1812. doi: 10.2460/javma.2002.220.1807
  10. Kano R, Aramaki C, Murayama N, Mori Y, Yamagishi K, Yokoi S, et al. High multi-­azole-resistant Malassezia pachydermatis clinical isolates from canine Malassezia dermatitis. Med Mycol. 2020;58(2):197—200. doi: 10.1093/mmy/myz037
  11. Sachivkina N, Karamyan A, Petrukhina O, Kuznetsova O, Neborak E, Ibragimova A. A rabbit model of ear otitis established using the Malassezia pachydermatis strain C23 from dogs. Veterinary World. 2023;16(11):2192—2199. doi: 10.14202/vetworld.2023.2192-2199
  12. Sachivkina NP, Kravtsov EG, Wasileva EA, Anokchina IV, Dalin MV. Efficiency of lyticase (bacterial enzyme) in experimental candidal vaginitis in mice. Bull Exp Biol Med. 2010;149(6):727—730. doi: 10.1007/s10517-010-1037-6
  13. Vis JY, Huisman A. Verification and quality control of routine hematology analyzers. Int J Lab Hematol. 2016;38(S1):100—109. doi: 10.1111/ijlh.12503
  14. Thammasit P, Laliam A, Chaicumpar K, Pruksaphon K, Nosanchuk JD, Youngchim S. Differential lipase virulence in Malassezia furfur dimorphism isolated from pityriasis versicolor patients and healthy individuals. Mycoses. 2023;66(6):540—549. doi: 10.1111/myc.13580
  15. Park M, Park S, Jung WH. Skin commensal fungus Malassezia and its lipases. J Microbiol Biotechnol. 2021;31(5):637—644. doi: 10.4014/jmb.2012.12048
  16. Juntachai W, Oura T, Murayama SY, Kajiwara S. The lipolytic enzymes activities of Malassezia species. Med Mycol. 2009;47(5):477—484. doi: 10.1080/13693780802314825

Supplementary files

Supplementary Files
Action
1. JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).